• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

外泌体环状 RNAs 在乳腺癌中的研究前景:现状与未来。

Prospect of exosomal circular RNAs in breast Cancer: presents and future.

机构信息

Department of Biology, Faculty of Sciences, Shahid Bahonar University of Kerman, Kerman, Iran.

Cancer Immunology Project (CIP), Universal Scientific Education and Research Network (USERN), Tehran, Iran.

出版信息

Mol Biol Rep. 2022 Jul;49(7):6997-7011. doi: 10.1007/s11033-022-07472-4. Epub 2022 May 9.

DOI:10.1007/s11033-022-07472-4
PMID:35534582
Abstract

Implementing precision oncology for breast cancer (BC) is a critical method for improving patient outcomes, which relies on the use of reliable biomarkers to be effective and safe. exosomes represent a potential alternative for the diagnosis and therapy of BC, As a "liquid biopsy" and a novel source for biomarkers. Exosomes are nanoscale phospholipid bilayer vesicles released by most cells that contain a large payload of various RNA species that can alter recipient cell activity. Circular RNAs (circRNAs) were recently revealed as a looping subclass of competing endogenous noncoding RNAs (ceRNAs) capable of microRNA sponging to regulate gene expression. They provide critical regulatory functions in carcinogenesis, proliferation, invasion, metastasis, and treatment resistance, as well as cancer prognostic. However, there is still a major gap in our understanding of the role of circRNA in the advancement of BC. CircRNAs are abundant in exosomes, according to various studies, and exosomal circRNAs (exo-circRNAs) play a significant role in cancer biology. Exo-circRNAs can be picked up by nearby or distant cells, affecting many features of the target cells' pathophysiological states, thus boosting cell communication and tumor spread. In this review, we have briefly summarized the major properties and functions of exosomes. Then, we have focused on exo-circRNAs, discussing their potential roles in both driving and inhibiting BC, as well as for cancer diagnosis, prognosis, and monitoring.

摘要

将精准肿瘤学应用于乳腺癌 (BC) 是改善患者预后的关键方法,这依赖于使用可靠的生物标志物来实现有效和安全。外泌体作为一种“液体活检”和新的生物标志物来源,代表了 BC 诊断和治疗的潜在选择。外泌体是大多数细胞释放的纳米级磷脂双层囊泡,其中包含大量各种 RNA 种类,可以改变受体细胞的活性。环状 RNA (circRNA) 最近被揭示为竞争性内源性非编码 RNA (ceRNA) 的一种环状亚类,能够通过微 RNA 海绵作用来调节基因表达。它们在致癌作用、增殖、侵袭、转移和治疗耐药性以及癌症预后中提供关键的调节功能。然而,我们对 circRNA 在 BC 进展中的作用的理解仍然存在很大差距。根据各种研究,circRNA 在细胞外体中含量丰富,外泌体 circRNA (exo-circRNA) 在癌症生物学中发挥着重要作用。exo-circRNA 可以被附近或远处的细胞摄取,影响靶细胞病理生理状态的许多特征,从而增强细胞间的通讯和肿瘤扩散。在这篇综述中,我们简要总结了外泌体的主要特性和功能。然后,我们集中讨论了 exo-circRNA,讨论了它们在驱动和抑制 BC 以及癌症诊断、预后和监测中的潜在作用。

相似文献

1
Prospect of exosomal circular RNAs in breast Cancer: presents and future.外泌体环状 RNAs 在乳腺癌中的研究前景:现状与未来。
Mol Biol Rep. 2022 Jul;49(7):6997-7011. doi: 10.1007/s11033-022-07472-4. Epub 2022 May 9.
2
Spotlight on Exosomal Non-Coding RNAs in Breast Cancer: An In Silico Analysis to Identify Potential lncRNA/circRNA-miRNA-Target Axis.聚焦乳腺癌中的外泌体非编码 RNA:lncRNA/circRNA-miRNA-靶轴的计算分析。
Int J Mol Sci. 2022 Jul 28;23(15):8351. doi: 10.3390/ijms23158351.
3
Circular RNA; a new biomarker for breast cancer: A systematic review.环状 RNA;乳腺癌的新型生物标志物:系统评价。
J Cell Physiol. 2020 Jul;235(7-8):5501-5510. doi: 10.1002/jcp.29558. Epub 2020 Jan 27.
4
Circular RNAs in Breast Cancer: An Update.环状 RNA 在乳腺癌中的研究进展。
Biomolecules. 2024 Jan 29;14(2):158. doi: 10.3390/biom14020158.
5
The emerging roles of exosomal circRNAs in diseases.外泌体 circRNAs 在疾病中的新兴作用。
Clin Transl Oncol. 2021 Jun;23(6):1020-1033. doi: 10.1007/s12094-020-02485-6. Epub 2020 Sep 15.
6
Roles and clinical application of exosomal circRNAs in the diagnosis and treatment of malignant tumors.外泌体 circRNAs 在恶性肿瘤诊断和治疗中的作用及临床应用。
J Transl Med. 2022 Apr 5;20(1):161. doi: 10.1186/s12967-022-03367-x.
7
Tumor Cells-derived exosomal CircRNAs: Novel cancer drivers, molecular mechanisms, and clinical opportunities.肿瘤细胞衍生的外泌体环状RNA:新型癌症驱动因素、分子机制及临床机遇
Biochem Pharmacol. 2022 Jun;200:115038. doi: 10.1016/j.bcp.2022.115038. Epub 2022 Apr 12.
8
Exosomal circRNAs as novel cancer biomarkers: Challenges and opportunities.外泌体环状 RNA 作为新型癌症生物标志物:挑战与机遇。
Int J Biol Sci. 2021 Jan 14;17(2):562-573. doi: 10.7150/ijbs.48782. eCollection 2021.
9
Comprehensive analysis of the exosomal circRNA-miRNA-mRNA network in breast cancer.乳腺癌外泌体 circRNA-miRNA-mRNA 网络的综合分析。
J Gene Med. 2023 Jul;25(7):e3500. doi: 10.1002/jgm.3500. Epub 2023 Apr 2.
10
Breast cancer derived exosomes promoted angiogenesis of endothelial cells in microenvironment via circHIPK3/miR-124-3p/MTDH axis.乳腺癌来源的外泌体通过 circHIPK3/miR-124-3p/MTDH 轴促进微环境中内皮细胞的血管生成。
Cell Signal. 2022 Jul;95:110338. doi: 10.1016/j.cellsig.2022.110338. Epub 2022 Apr 20.

引用本文的文献

1
Tumor-derived extracellular vesicles: key drivers of immunomodulation in breast cancer.肿瘤衍生的细胞外囊泡:乳腺癌免疫调节的关键驱动因素
Front Immunol. 2025 Mar 4;16:1548535. doi: 10.3389/fimmu.2025.1548535. eCollection 2025.
2
Downregulated circPOKE promotes breast cancer metastasis through activation of the USP10-Snail axis.下调的 circPOKE 通过激活 USP10-Snail 轴促进乳腺癌转移。
Oncogene. 2023 Oct;42(44):3236-3251. doi: 10.1038/s41388-023-02823-2. Epub 2023 Sep 16.
3
Exosomes are involved in the intercellular transfer of rapamycin resistance in the breast cancer cells.

本文引用的文献

1
The Hippo Signaling Pathway in Drug Resistance in Cancer.癌症耐药中的河马信号通路
Cancers (Basel). 2021 Jan 16;13(2):318. doi: 10.3390/cancers13020318.
2
Cell-cycle arrest and senescence in TP53-wild type renal carcinoma by enhancer RNA-P53-bound enhancer regions 2 (p53BER2) in a p53-dependent pathway.p53 依赖性途径中增强子 RNA-P53 结合增强子区域 2(p53BER2)诱导 TP53 野生型肾细胞癌细胞周期停滞和衰老。
Cell Death Dis. 2021 Jan 5;12(1):1. doi: 10.1038/s41419-020-03229-8.
3
The emerging roles of exosomal circRNAs in diseases.
外泌体参与乳腺癌细胞中雷帕霉素抗性的细胞间转移。
Bioimpacts. 2023;13(4):313-321. doi: 10.34172/bi.2023.27490. Epub 2023 Jul 1.
4
Non-Coding RNAs Modulating Estrogen Signaling and Response to Endocrine Therapy in Breast Cancer.非编码RNA对乳腺癌雌激素信号传导及内分泌治疗反应的调控
Cancers (Basel). 2023 Mar 7;15(6):1632. doi: 10.3390/cancers15061632.
5
Potential of blood exosomal ENAH, SEPT9, EGF, MMP-9 and CXCL8 for the early screening of breast cancer.血液外泌体中ENAH、SEPT9、表皮生长因子(EGF)、基质金属蛋白酶-9(MMP-9)和CXC趋化因子配体8(CXCL8)用于乳腺癌早期筛查的潜力
Oncol Lett. 2022 Nov 3;24(6):460. doi: 10.3892/ol.2022.13580. eCollection 2022 Dec.
外泌体 circRNAs 在疾病中的新兴作用。
Clin Transl Oncol. 2021 Jun;23(6):1020-1033. doi: 10.1007/s12094-020-02485-6. Epub 2020 Sep 15.
4
Tumor-derived exosomes: the next generation of promising cell-free vaccines in cancer immunotherapy.肿瘤衍生外泌体:癌症免疫治疗中下一代有前景的无细胞疫苗。
Oncoimmunology. 2020 Jun 16;9(1):1779991. doi: 10.1080/2162402X.2020.1779991.
5
CircRNA circ_0072995 promotes the progression of epithelial ovarian cancer by modulating miR-147a/CDK6 axis.环状RNA circ_0072995通过调控miR-147a/CDK6轴促进上皮性卵巢癌进展。
Aging (Albany NY). 2020 Sep 2;12(17):17209-17223. doi: 10.18632/aging.103668.
6
The potential role of tumor-derived exosomes in diagnosis, prognosis, and response to therapy in cancer.肿瘤源性外泌体在癌症诊断、预后和治疗反应中的潜在作用。
Expert Opin Biol Ther. 2021 Feb;21(2):241-258. doi: 10.1080/14712598.2020.1813276. Epub 2020 Sep 8.
7
Exosomal circular RNA sorting mechanisms and their function in promoting or inhibiting cancer.外泌体环状RNA分选机制及其在促进或抑制癌症中的作用
Oncol Lett. 2020 May;19(5):3369-3380. doi: 10.3892/ol.2020.11449. Epub 2020 Mar 6.
8
EMT related circular RNA expression profiles identify circSCYL2 as a novel molecule in breast tumor metastasis.EMT 相关环状 RNA 表达谱鉴定 circSCYL2 为乳腺癌转移中的新型分子。
Int J Mol Med. 2020 Jun;45(6):1697-1710. doi: 10.3892/ijmm.2020.4550. Epub 2020 Mar 24.
9
Breast cancer-derived exosomes: Tumor progression and therapeutic agents.乳腺癌来源的外泌体:肿瘤进展和治疗剂。
J Cell Physiol. 2020 Oct;235(10):6345-6356. doi: 10.1002/jcp.29668. Epub 2020 Mar 26.
10
Biological Roles and Mechanisms of Circular RNA in Human Cancers.环状RNA在人类癌症中的生物学作用及机制
Onco Targets Ther. 2020 Mar 9;13:2067-2092. doi: 10.2147/OTT.S233672. eCollection 2020.